Who We Are

Trinadh Industries Pvt. Ltd. is building an integrated pharmaceutical ecosystem that brings together medicinal chemistry, peptide chemistry, oligonucleotide chemistry, process chemistry, analytical sciences, quality, and regulatory affairs — alongside our established manufacturing and supply of APIs, KSMs, and Intermediates from IDA Nacharam, Hyderabad. Our multidisciplinary organization connects scientific expertise with practical pharmaceutical development, supporting partners from early-stage research through development, quality, regulatory readiness, and global supply.

One Organization. Multiple Scientific Disciplines. One Purpose.

Our Vision

To advance human health by transforming innovative chemistry and scientific research into better solutions for patients worldwide — and to become a globally trusted pharmaceutical research and innovation partner.

Our Mission

To enable faster and smarter pharmaceutical innovation through research, chemistry, analytical development, and collaboration, addressing the world's most challenging diseases — helping partners move promising ideas from concept to molecule, from molecule toward development, and ultimately toward patients.

Our Values

Science Integrity Quality Innovation Collaboration Patient Impact

USP/BP/EP

Certified Products

50+

Products

Global

Supply Network

Expert

Team

Our Organization

How Trinadh Industries is structured

Our Board of Directors is supported by a Scientific Advisory Board, Global Business Development, Regulatory & Compliance Advisory, and Technology & Innovation Advisory. The Chief Executive Officer leads strategic vision, global growth, and partnerships across seven operating divisions.
Chief Scientific Officer

R&D Division

  • Medicinal & Peptide Chemistry
  • Oligonucleotide Chemistry
  • Bioconjugation & Advanced Therapeutics
  • Computational & AI-Enabled Discovery
  • Formulation & Drug Delivery
Head – Process Development

Process Development Division

  • Process Chemistry R&D
  • API & Intermediate Development
  • Technology Transfer & Scale-Up
Head – Analytical Development

Analytical Sciences Division

  • Analytical Method Development
  • Characterization & Impurity Profiling
  • Stability Studies
  • HPLC | LC-MS | GC | NMR | IR | UV
Head – Quality Assurance

Quality Division

  • Quality Assurance (QA)
  • Quality Control (QC)
  • GxP Compliance Support
  • Supplier & Vendor Quality
Head – Regulatory Affairs

Regulatory Affairs Division

  • Regulatory Strategy
  • Technical Documentation
  • Compliance & Intelligence
  • Regulatory Communication with Authorities
Head – Operations

Operations & Supply Chain

  • Manufacturing Support
  • Procurement & Supply Chain
  • Project Management
  • Environment, Health & Safety
Head – Corporate Services

Corporate Functions

  • Finance & Accounts
  • Human Resources
  • Legal & Intellectual Property
  • Information Technology
  • Administration & Facilities

Research, Quality & Regulatory Departments

Multidisciplinary expertise, working together

Our teams work together to support pharmaceutical research and development with a strong commitment to scientific excellence, quality, compliance, and patient safety.

Discovery & Molecular Innovation

Medicinal Chemistry R&D

Design • Synthesis • Optimization

Design, synthesis, and optimization of innovative small molecules — supporting hit exploration, lead optimization, structure–activity relationship studies, and development of novel chemical entities across multiple therapeutic areas.

Computational & AI-Enabled Drug Discovery

Molecular Design • Data Science • Prediction

Computational approaches to accelerate pharmaceutical research, including molecular modeling, chemical data analysis, structure–activity relationship analysis, and AI-assisted discovery strategies.

Advanced Molecule Platforms

Peptide Chemistry R&D

Design • Synthesis • Purification • Characterization

Research and development of peptides and peptide-based molecules, including challenging sequences and specialized peptide chemistry — with a focus on synthesis, purification, characterization, and process improvement.

Oligonucleotide Chemistry R&D

Design • Synthesis • Purification • Characterization

Synthesis and analytical characterization of oligonucleotide-based molecules, supporting emerging therapeutic approaches including antisense, RNA-targeting, and other nucleic-acid-based technologies.

Bioconjugation & Advanced Therapeutics

Conjugation • Biomolecules • Next-Gen Therapeutics

Research at the interface of chemistry and biology — biomolecular modification, conjugation technologies, and emerging approaches for next-generation therapeutic development.

Process & Development Sciences

Process Chemistry R&D

Route Scouting • Optimization • Scale-Up

Transforming laboratory chemistry into practical, robust, and scalable processes — route scouting, process optimization, impurity control, reaction efficiency, and scale-up strategies.

API & Pharmaceutical Development

Intermediates • APIs • Development

Development of pharmaceutical compounds and advanced intermediates, integrating synthetic chemistry, process understanding, analytical development, and quality considerations.

Formulation & Drug Delivery R&D

Delivery • Stability • Performance

Research to improve the solubility, stability, delivery, and performance of pharmaceutical molecules and advanced therapeutic candidates.

Analytical Sciences

Analytical Development R&D

Identity • Purity • Impurities • Stability

Developing and optimizing analytical methods to identify, characterize, and control pharmaceutical molecules and intermediates — purity assessment, impurity profiling, structural characterization, and stability studies using HPLC, LC-MS, GC, NMR, IR and UV techniques.

Quality Organization

Quality Assurance & Quality Control

Quality • Data Integrity • Continuous Improvement

Quality systems, documentation, data integrity, SOPs, quality oversight, laboratory practices, investigations, deviations, and CAPA — integrated throughout our scientific workflow rather than treated as a final checkpoint.

Regulatory & Compliance

Regulatory Affairs

Strategy • Documentation • Regulatory Readiness

Scientifically sound and compliant documentation for pharmaceutical R&D — regulatory strategy, technical documentation, submission support, compliance assessment, and communication with relevant authorities.

Our Integrated Scientific Model

From molecule to medicine, in eight steps

DISCOVER

Medicinal & computational chemistry, AI-enabled discovery

DESIGN

Small molecules, peptides, oligonucleotides, advanced therapeutics

CREATE

Synthetic chemistry, process chemistry, bioconjugation

UNDERSTAND

Analytical development, characterization, stability

DEVELOP

Process development, API development, formulation

ASSURE

Quality assurance, quality control, data integrity

ENABLE

Regulatory affairs, technical documentation, readiness

Innovate for Patients Worldwide

Research Focus Areas

Our multidisciplinary capabilities applied across challenging disease areas

Oncology

Cancer research and therapeutic development

Diabetes & Metabolic Diseases

Metabolic disorders and related therapeutic research

Neuroscience

Neurological and neurodegenerative disease research

Cardiovascular Diseases

Heart and vascular health research

Infectious Diseases

Global health challenges

Inflammation & Immunology

Immune-mediated and inflammatory disorders

Rare Diseases

Underserved and challenging medical needs

Other Unmet Medical Needs

Emerging therapeutic areas requiring innovative chemistry

Our Commitment

Science with integrity. Quality by design. Innovation with purpose. We believe meaningful pharmaceutical innovation requires more than chemistry alone — it requires science, technology, quality, regulatory expertise, and collaboration.

Our ambition is to collaborate with pharmaceutical companies, biotechnology companies, research institutions, innovators, and scientific partners worldwide to accelerate the journey from scientific ideas toward better therapeutic solutions.

From Molecule to Medicine. Toward a Healthier Tomorrow.